Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Vertigo Market Research Report with Opportunities and Strategies to Boost Growth- COVID-19 Impact and Recovery

  • MAI4620563
  • 112 Pages
  • August 2021
  • Pharmaceuticals
Download Sample    Get Discount   
 
Vertigo is a medical condition, wherein a person feels he or she or the objects around are moving when they are not. The condition is often related to walking impairment, sweating, and nausea. Vertigo is the most common form of dizziness and the cause of this condition could be peripheral and central.

Based on the Vertigo market development status, competitive landscape and development model in different regions of the world, this report is dedicated to providing niche markets, potential risks and comprehensive competitive strategy analysis in different fields. From the competitive advantages of different types of products and services, the development opportunities and consumption characteristics and structure analysis of the downstream application fields are all analyzed in detail. To Boost Growth during the epidemic era, this report analyzes in detail for the potential risks and opportunities which can be focused on.

In Chapter 2.4 of the report, we share our perspectives for the impact of COVID-19 from the long and short term.

In chapter 3.4, we provide the influence of the crisis on the industry chain, especially for marketing channels.

In chapters 8-13, we update the timely industry economic revitalization plan of the country-wise government.

Key players in the global Vertigo market covered in Chapter 5:

Liaoyuan Silver Eagle Pharmaceutical Co. Ltd.

AstraZeneca

Sanofi

Intas Pharmaceutical Ltd.

Marc Laboratories

LGM Pharma

Pfizer, Inc.

Medichem S.A.

Sun Pharmaceutical Industries Ltd.

Cadila Pharmaceuticals

In Chapter 6, on the basis of types, the Vertigo market from 2015 to 2025 is primarily split into:

Drugs

Injection

Operation

In Chapter 7, on the basis of applications, the Vertigo market from 2015 to 2025 covers:

Vestibular Disorders

Non-Vestibular Disorders

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 8-13:

North America (Covered in Chapter 9)

United States

Canada

Mexico

Europe (Covered in Chapter 10)

Germany

UK

France

Italy

Spain

Russia

Others

Asia-Pacific (Covered in Chapter 11)

China

Japan

South Korea

Australia

India

South America (Covered in Chapter 12)

Brazil

Argentina

Columbia

Middle East and Africa (Covered in Chapter 13)

UAE

Egypt

South Africa

Years considered for this report:

Historical Years: 2015-2019

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2020-2025

Table of Content

1 Market Overview

1.1 Product Definition and Market Characteristics

1.2 Global Vertigo Market Size

1.3 Market Segmentation

1.4 Global Macroeconomic Analysis

1.5 SWOT Analysis

2. Market Dynamics

2.1 Market Drivers

2.2 Market Constraints and Challenges

2.3 Emerging Market Trends

2.4 Impact of COVID-19

2.4.1 Short-term Impact

2.4.2 Long-term Impact

3 Associated Industry Assessment

3.1 Supply Chain Analysis

3.2 Industry Active Participants

3.2.1 Suppliers of Raw Materials

3.2.2 Key Distributors/Retailers

3.3 Alternative Analysis

3.4 The Impact of Covid-19 From the Perspective of Industry Chain

4 Market Competitive Landscape

4.1 Industry Leading Players

4.2 Industry News

4.2.1 Key Product Launch News

4.2.2 M&A and Expansion Plans

5 Analysis of Leading Companies

5.1 Liaoyuan Silver Eagle Pharmaceutical Co. Ltd.

5.1.1 Liaoyuan Silver Eagle Pharmaceutical Co. Ltd. Company Profile

5.1.2 Liaoyuan Silver Eagle Pharmaceutical Co. Ltd. Business Overview

5.1.3 Liaoyuan Silver Eagle Pharmaceutical Co. Ltd. Vertigo Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)

5.1.4 Liaoyuan Silver Eagle Pharmaceutical Co. Ltd. Vertigo Products Introduction

5.2 AstraZeneca

5.2.1 AstraZeneca Company Profile

5.2.2 AstraZeneca Business Overview

5.2.3 AstraZeneca Vertigo Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)

5.2.4 AstraZeneca Vertigo Products Introduction

5.3 Sanofi

5.3.1 Sanofi Company Profile

5.3.2 Sanofi Business Overview

5.3.3 Sanofi Vertigo Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)

5.3.4 Sanofi Vertigo Products Introduction

5.4 Intas Pharmaceutical Ltd.

5.4.1 Intas Pharmaceutical Ltd. Company Profile

5.4.2 Intas Pharmaceutical Ltd. Business Overview

5.4.3 Intas Pharmaceutical Ltd. Vertigo Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)

5.4.4 Intas Pharmaceutical Ltd. Vertigo Products Introduction

5.5 Marc Laboratories

5.5.1 Marc Laboratories Company Profile

5.5.2 Marc Laboratories Business Overview

5.5.3 Marc Laboratories Vertigo Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)

5.5.4 Marc Laboratories Vertigo Products Introduction

5.6 LGM Pharma

5.6.1 LGM Pharma Company Profile

5.6.2 LGM Pharma Business Overview

5.6.3 LGM Pharma Vertigo Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)

5.6.4 LGM Pharma Vertigo Products Introduction

5.7 Pfizer, Inc.

5.7.1 Pfizer, Inc. Company Profile

5.7.2 Pfizer, Inc. Business Overview

5.7.3 Pfizer, Inc. Vertigo Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)

5.7.4 Pfizer, Inc. Vertigo Products Introduction

5.8 Medichem S.A.

5.8.1 Medichem S.A. Company Profile

5.8.2 Medichem S.A. Business Overview

5.8.3 Medichem S.A. Vertigo Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)

5.8.4 Medichem S.A. Vertigo Products Introduction

5.9 Sun Pharmaceutical Industries Ltd.

5.9.1 Sun Pharmaceutical Industries Ltd. Company Profile

5.9.2 Sun Pharmaceutical Industries Ltd. Business Overview

5.9.3 Sun Pharmaceutical Industries Ltd. Vertigo Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)

5.9.4 Sun Pharmaceutical Industries Ltd. Vertigo Products Introduction

5.10 Cadila Pharmaceuticals

5.10.1 Cadila Pharmaceuticals Company Profile

5.10.2 Cadila Pharmaceuticals Business Overview

5.10.3 Cadila Pharmaceuticals Vertigo Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)

5.10.4 Cadila Pharmaceuticals Vertigo Products Introduction

6 Market Analysis and Forecast, By Product Types

6.1 Global Vertigo Sales, Revenue and Market Share by Types (2015-2020)

6.1.1 Global Vertigo Sales and Market Share by Types (2015-2020)

6.1.2 Global Vertigo Revenue and Market Share by Types (2015-2020)

6.1.3 Global Vertigo Price by Types (2015-2020)

6.2 Global Vertigo Market Forecast by Types (2020-2025)

6.2.1 Global Vertigo Market Forecast Sales and Market Share by Types (2020-2025)

6.2.2 Global Vertigo Market Forecast Revenue and Market Share by Types (2020-2025)

6.3 Global Vertigo Sales, Price and Growth Rate by Types (2015-2020)

6.3.1 Global Vertigo Sales, Price and Growth Rate of Drugs

6.3.2 Global Vertigo Sales, Price and Growth Rate of Injection

6.3.3 Global Vertigo Sales, Price and Growth Rate of Operation

6.4 Global Vertigo Market Revenue and Sales Forecast, by Types (2020-2025)

6.4.1 Drugs Market Revenue and Sales Forecast (2020-2025)

6.4.2 Injection Market Revenue and Sales Forecast (2020-2025)

6.4.3 Operation Market Revenue and Sales Forecast (2020-2025)

7 Market Analysis and Forecast, By Applications

7.1 Global Vertigo Sales, Revenue and Market Share by Applications (2015-2020)

7.1.1 Global Vertigo Sales and Market Share by Applications (2015-2020)

7.1.2 Global Vertigo Revenue and Market Share by Applications (2015-2020)

7.2 Global Vertigo Market Forecast by Applications (2020-2025)

7.2.1 Global Vertigo Market Forecast Sales and Market Share by Applications (2020-2025)

7.2.2 Global Vertigo Market Forecast Revenue and Market Share by Applications (2020-2025)

7.3 Global Revenue, Sales and Growth Rate by Applications (2015-2020)

7.3.1 Global Vertigo Revenue, Sales and Growth Rate of Vestibular Disorders (2015-2020)

7.3.2 Global Vertigo Revenue, Sales and Growth Rate of Non-Vestibular Disorders (2015-2020)

7.4 Global Vertigo Market Revenue and Sales Forecast, by Applications (2020-2025)

7.4.1 Vestibular Disorders Market Revenue and Sales Forecast (2020-2025)

7.4.2 Non-Vestibular Disorders Market Revenue and Sales Forecast (2020-2025)

8 Market Analysis and Forecast, By Regions

8.1 Global Vertigo Sales by Regions (2015-2020)

8.2 Global Vertigo Market Revenue by Regions (2015-2020)

8.3 Global Vertigo Market Forecast by Regions (2020-2025)

9 North America Vertigo Market Analysis

9.1 Market Overview and Prospect Analysis

9.2 North America Vertigo Market Sales and Growth Rate (2015-2020)

9.3 North America Vertigo Market Revenue and Growth Rate (2015-2020)

9.4 North America Vertigo Market Forecast

9.5 The Influence of COVID-19 on North America Market

9.6 North America Vertigo Market Analysis by Country

9.6.1 U.S. Vertigo Sales and Growth Rate

9.6.2 Canada Vertigo Sales and Growth Rate

9.6.3 Mexico Vertigo Sales and Growth Rate

10 Europe Vertigo Market Analysis

10.1 Market Overview and Prospect Analysis

10.2 Europe Vertigo Market Sales and Growth Rate (2015-2020)

10.3 Europe Vertigo Market Revenue and Growth Rate (2015-2020)

10.4 Europe Vertigo Market Forecast

10.5 The Influence of COVID-19 on Europe Market

10.6 Europe Vertigo Market Analysis by Country

10.6.1 Germany Vertigo Sales and Growth Rate

10.6.2 United Kingdom Vertigo Sales and Growth Rate

10.6.3 France Vertigo Sales and Growth Rate

10.6.4 Italy Vertigo Sales and Growth Rate

10.6.5 Spain Vertigo Sales and Growth Rate

10.6.6 Russia Vertigo Sales and Growth Rate

11 Asia-Pacific Vertigo Market Analysis

11.1 Market Overview and Prospect Analysis

11.2 Asia-Pacific Vertigo Market Sales and Growth Rate (2015-2020)

11.3 Asia-Pacific Vertigo Market Revenue and Growth Rate (2015-2020)

11.4 Asia-Pacific Vertigo Market Forecast

11.5 The Influence of COVID-19 on Asia Pacific Market

11.6 Asia-Pacific Vertigo Market Analysis by Country

11.6.1 China Vertigo Sales and Growth Rate

11.6.2 Japan Vertigo Sales and Growth Rate

11.6.3 South Korea Vertigo Sales and Growth Rate

11.6.4 Australia Vertigo Sales and Growth Rate

11.6.5 India Vertigo Sales and Growth Rate

12 South America Vertigo Market Analysis

12.1 Market Overview and Prospect Analysis

12.2 South America Vertigo Market Sales and Growth Rate (2015-2020)

12.3 South America Vertigo Market Revenue and Growth Rate (2015-2020)

12.4 South America Vertigo Market Forecast

12.5 The Influence of COVID-19 on South America Market

12.6 South America Vertigo Market Analysis by Country

12.6.1 Brazil Vertigo Sales and Growth Rate

12.6.2 Argentina Vertigo Sales and Growth Rate

12.6.3 Columbia Vertigo Sales and Growth Rate

13 Middle East and Africa Vertigo Market Analysis

13.1 Market Overview and Prospect Analysis

13.2 Middle East and Africa Vertigo Market Sales and Growth Rate (2015-2020)

13.3 Middle East and Africa Vertigo Market Revenue and Growth Rate (2015-2020)

13.4 Middle East and Africa Vertigo Market Forecast

13.5 The Influence of COVID-19 on Middle East and Africa Market

13.6 Middle East and Africa Vertigo Market Analysis by Country

13.6.1 UAE Vertigo Sales and Growth Rate

13.6.2 Egypt Vertigo Sales and Growth Rate

13.6.3 South Africa Vertigo Sales and Growth Rate

14 Conclusions and Recommendations

14.1 Key Market Findings and Prospects

14.2 Advice for Investors

15 Appendix

15.1 Methodology

15.2 Research Data Source

List of Tables and Figures

Figure Product Picture

Figure Global Vertigo Market Size and Growth Rate 2015-2025

Table Vertigo Key Market Segments

Figure Global Vertigo Market Revenue ($) Segment by Type from 2015-2020

Figure Global Vertigo Market Revenue ($) Segment by Applications from 2015-2020

Table SWOT Analysis

Figure Global COVID-19 Status

Figure Supply Chain

Table Major Players Headquarters, and Service Area of Vertigo

Table Major Players Revenue in 2019

Figure Major Players Revenue Share in 2019

Table Liaoyuan Silver Eagle Pharmaceutical Co. Ltd. Company Profile

Table Liaoyuan Silver Eagle Pharmaceutical Co. Ltd. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Liaoyuan Silver Eagle Pharmaceutical Co. Ltd. Production and Growth Rate

Figure Liaoyuan Silver Eagle Pharmaceutical Co. Ltd. Market Revenue ($) Market Share 2015-2020

Table AstraZeneca Company Profile

Table AstraZeneca Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure AstraZeneca Production and Growth Rate

Figure AstraZeneca Market Revenue ($) Market Share 2015-2020

Table Sanofi Company Profile

Table Sanofi Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Sanofi Production and Growth Rate

Figure Sanofi Market Revenue ($) Market Share 2015-2020

Table Intas Pharmaceutical Ltd. Company Profile

Table Intas Pharmaceutical Ltd. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Intas Pharmaceutical Ltd. Production and Growth Rate

Figure Intas Pharmaceutical Ltd. Market Revenue ($) Market Share 2015-2020

Table Marc Laboratories Company Profile

Table Marc Laboratories Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Marc Laboratories Production and Growth Rate

Figure Marc Laboratories Market Revenue ($) Market Share 2015-2020

Table LGM Pharma Company Profile

Table LGM Pharma Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure LGM Pharma Production and Growth Rate

Figure LGM Pharma Market Revenue ($) Market Share 2015-2020

Table Pfizer, Inc. Company Profile

Table Pfizer, Inc. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Pfizer, Inc. Production and Growth Rate

Figure Pfizer, Inc. Market Revenue ($) Market Share 2015-2020

Table Medichem S.A. Company Profile

Table Medichem S.A. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Medichem S.A. Production and Growth Rate

Figure Medichem S.A. Market Revenue ($) Market Share 2015-2020

Table Sun Pharmaceutical Industries Ltd. Company Profile

Table Sun Pharmaceutical Industries Ltd. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Sun Pharmaceutical Industries Ltd. Production and Growth Rate

Figure Sun Pharmaceutical Industries Ltd. Market Revenue ($) Market Share 2015-2020

Table Cadila Pharmaceuticals Company Profile

Table Cadila Pharmaceuticals Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Cadila Pharmaceuticals Production and Growth Rate

Figure Cadila Pharmaceuticals Market Revenue ($) Market Share 2015-2020

Table Global Vertigo Sales by Types (2015-2020)

Table Global Vertigo Sales Share by Types (2015-2020)

Table Global Vertigo Revenue ($) by Types (2015-2020)

Table Global Vertigo Revenue Share by Types (2015-2020)

Table Global Vertigo Price ($) by Types (2015-2020)

Table Global Vertigo Market Forecast Sales by Types (2020-2025)

Table Global Vertigo Market Forecast Sales Share by Types (2020-2025)

Table Global Vertigo Market Forecast Revenue ($) by Types (2020-2025)

Table Global Vertigo Market Forecast Revenue Share by Types (2020-2025)

Figure Global Drugs Sales and Growth Rate (2015-2020)

Figure Global Drugs Price (2015-2020)

Figure Global Injection Sales and Growth Rate (2015-2020)

Figure Global Injection Price (2015-2020)

Figure Global Operation Sales and Growth Rate (2015-2020)

Figure Global Operation Price (2015-2020)

Figure Global Vertigo Market Revenue ($) and Growth Rate Forecast of Drugs (2020-2025)

Figure Global Vertigo Sales and Growth Rate Forecast of Drugs (2020-2025)

Figure Global Vertigo Market Revenue ($) and Growth Rate Forecast of Injection (2020-2025)

Figure Global Vertigo Sales and Growth Rate Forecast of Injection (2020-2025)

Figure Global Vertigo Market Revenue ($) and Growth Rate Forecast of Operation (2020-2025)

Figure Global Vertigo Sales and Growth Rate Forecast of Operation (2020-2025)

Table Global Vertigo Sales by Applications (2015-2020)

Table Global Vertigo Sales Share by Applications (2015-2020)

Table Global Vertigo Revenue ($) by Applications (2015-2020)

Table Global Vertigo Revenue Share by Applications (2015-2020)

Table Global Vertigo Market Forecast Sales by Applications (2020-2025)

Table Global Vertigo Market Forecast Sales Share by Applications (2020-2025)

Table Global Vertigo Market Forecast Revenue ($) by Applications (2020-2025)

Table Global Vertigo Market Forecast Revenue Share by Applications (2020-2025)

Figure Global Vestibular Disorders Sales and Growth Rate (2015-2020)

Figure Global Vestibular Disorders Price (2015-2020)

Figure Global Non-Vestibular Disorders Sales and Growth Rate (2015-2020)

Figure Global Non-Vestibular Disorders Price (2015-2020)

Figure Global Vertigo Market Revenue ($) and Growth Rate Forecast of Vestibular Disorders (2020-2025)

Figure Global Vertigo Sales and Growth Rate Forecast of Vestibular Disorders (2020-2025)

Figure Global Vertigo Market Revenue ($) and Growth Rate Forecast of Non-Vestibular Disorders (2020-2025)

Figure Global Vertigo Sales and Growth Rate Forecast of Non-Vestibular Disorders (2020-2025)

Figure Global Vertigo Sales and Growth Rate (2015-2020)

Table Global Vertigo Sales by Regions (2015-2020)

Table Global Vertigo Sales Market Share by Regions (2015-2020)

Figure Global Vertigo Sales Market Share by Regions in 2019

Figure Global Vertigo Revenue and Growth Rate (2015-2020)

Table Global Vertigo Revenue by Regions (2015-2020)

Table Global Vertigo Revenue Market Share by Regions (2015-2020)

Figure Global Vertigo Revenue Market Share by Regions in 2019

Table Global Vertigo Market Forecast Sales by Regions (2020-2025)

Table Global Vertigo Market Forecast Sales Share by Regions (2020-2025)

Table Global Vertigo Market Forecast Revenue ($) by Regions (2020-2025)

Table Global Vertigo Market Forecast Revenue Share by Regions (2020-2025)

Figure North America Vertigo Market Sales and Growth Rate (2015-2020)

Figure North America Vertigo Market Revenue and Growth Rate (2015-2020)

Figure North America Vertigo Market Forecast Sales (2020-2025)

Figure North America Vertigo Market Forecast Revenue ($) (2020-2025)

Figure North America COVID-19 Status

Figure U.S. Vertigo Market Sales and Growth Rate (2015-2020)

Figure Canada Vertigo Market Sales and Growth Rate (2015-2020)

Figure Mexico Vertigo Market Sales and Growth Rate (2015-2020)

Figure Europe Vertigo Market Sales and Growth Rate (2015-2020)

Figure Europe Vertigo Market Revenue and Growth Rate (2015-2020)

Figure Europe Vertigo Market Forecast Sales (2020-2025)

Figure Europe Vertigo Market Forecast Revenue ($) (2020-2025)

Figure Europe COVID-19 Status

Figure Germany Vertigo Market Sales and Growth Rate (2015-2020)

Figure United Kingdom Vertigo Market Sales and Growth Rate (2015-2020)

Figure France Vertigo Market Sales and Growth Rate (2015-2020)

Figure Italy Vertigo Market Sales and Growth Rate (2015-2020)

Figure Spain Vertigo Market Sales and Growth Rate (2015-2020)

Figure Russia Vertigo Market Sales and Growth Rate (2015-2020)

Figure Asia-Pacific Vertigo Market Sales and Growth Rate (2015-2020)

Figure Asia-Pacific Vertigo Market Revenue and Growth Rate (2015-2020)

Figure Asia-Pacific Vertigo Market Forecast Sales (2020-2025)

Figure Asia-Pacific Vertigo Market Forecast Revenue ($) (2020-2025)

Figure Asia Pacific COVID-19 Status

Figure China Vertigo Market Sales and Growth Rate (2015-2020)

Figure Japan Vertigo Market Sales and Growth Rate (2015-2020)

Figure South Korea Vertigo Market Sales and Growth Rate (2015-2020)

Figure Australia Vertigo Market Sales and Growth Rate (2015-2020)

Figure India Vertigo Market Sales and Growth Rate (2015-2020)

Figure South America Vertigo Market Sales and Growth Rate (2015-2020)

Figure South America Vertigo Market Revenue and Growth Rate (2015-2020)

Figure South America Vertigo Market Forecast Sales (2020-2025)

Figure South America Vertigo Market Forecast Revenue ($) (2020-2025)

Figure Brazil Vertigo Market Sales and Growth Rate (2015-2020)

Figure Argentina Vertigo Market Sales and Growth Rate (2015-2020)

Figure Columbia Vertigo Market Sales and Growth Rate (2015-2020)

Figure Middle East and Africa Vertigo Market Sales and Growth Rate (2015-2020)

Figure Middle East and Africa Vertigo Market Revenue and Growth Rate (2015-2020)

Figure Middle East and Africa Vertigo Market Forecast Sales (2020-2025)

Figure Middle East and Africa Vertigo Market Forecast Revenue ($) (2020-2025)

Figure UAE Vertigo Market Sales and Growth Rate (2015-2020)

Figure Egypt Vertigo Market Sales and Growth Rate (2015-2020)

Figure South Africa Vertigo Market Sales and Growth Rate (2015-2020)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390